Coronavirus Research Tools

R&D Systems, a Bio-Techne brand, offers a large selection of antibodies for SARS‑CoV‑2 and COVID‑19 research. Our antibodies are essential tools that have supported pivotal research on SARS‑CoV‑2 recognition and viral infection and are being used to develop assays for SARS‑CoV‑2 detection.

Novus Biologicals, a Bio-Techne brand, specializes in providing tools to support emerging areas of research, such as the COVID‑19 pandemic. Their selection of SARS‑CoV‑2 proteins and antibodies have been used to further the understanding of SARS‑CoV‑2 infection, including by the CDC for the immunohistochemistry detection of SARS‑CoV‑2.

R&D Systems, a Bio-Techne brand, offers a wide selection of recombinant proteins for SARS‑CoV‑2 research, including the U.K. and South African variant Spike proteins. All of our proteins are produced and purified in-house and are rigorously tested for bioactivity and lot-to-lot consistency.

Bio‑Techne, through the Tocris brand, provides a wide range of small molecules for exploring different stages of the SARS‑CoV‑2 viral lifecycle. The Tocris catalog offers products for targets involved in viral cell entry, including ACE2, TMPRSS2, and targets important in viral replication, such as M^pro, PL^pro and RNA polymerase. The range includes FDA approved drugs, innovative new compounds, as well as fluorescent reagents.

Download our brochure to explore the tools from all the Bio-Techne brands that can support and further SARS-CoV-2 and COVID-19 research.

Watch this webinar to learn about the development of COVID-SeroIndex, a quantitative ELISA designed to measure SARS-CoV-2-IgG antibodies, through our partnership with Kantaro Biosciences – a Mount Sinai Venture.

Watch this webinar to see how flow cytometry can be used to investigate ACE-2 expression, monitor the immune response to SARS-CoV-2 infection, and evaluate the effectiveness of antibodies and/or small molecules to block SARS-CoV-2 binding to ACE-2.

In this webinar, Bio-Techne scientists are joined by Joep Beumer, from the Hans Clevers lab at the Hubrecht Institute, to discuss different aspects of COVID-19 research including the use of intestinal organoids to model SARS-CoV-2 infection.

Watch this webinar to learn how scientists from leading pharmaceutical companies use Bio-Techne’s automated analytical technologies throughout the the vaccine development workflow.

Watch this webinar to learn how the automated platforms from our ProteinSimple brand can be utilized for COVID-19 basic research and serological assay development.